img

Global Retail Drug Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Retail Drug Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body.
Due to the COVID-19 pandemic, the global Retail Drug market size was US$ 1176.9 million in 2024 and is forecast to a readjusted size of US$ 1438.9 million by 2034 with a CAGR of 2.9% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Generic Drug accounting for % of the Retail Drug global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital segment is altered to an % CAGR throughout this forecast period.
Increasing industry share of Asian economies in world trade and rapid industrialization in emerging economies are expected to boost demand in this region. Thus, APAC is expected to grow at a faster pace than other regions.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Retail Drug market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Retail Drug market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Retail Drug market. Readers of the report can become informed about current and future trends of the global Retail Drug market and how they will impact market growth during the forecast period.



By Company


CVS Caremark
Rite Aid
Target
Walgreens
Walmart
Segment by Type
Generic Drug
OTC Drug
Others

Segment by Application


Hospital
Clinic
Hoem Use
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Retail Drug in global and regional level.
Chapter 3Detailed analysis of Retail Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Retail Drug revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retail Drug Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Generic Drug
1.2.3 OTC Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Retail Drug Market Growth Rate by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Hoem Use
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Retail Drug Market Size (2018-2034)
2.2 Retail Drug Market Size across Key Geographies Worldwide: 2018 VS 2024 VS 2034
2.3 Global Retail Drug Market Size by Region (2018-2023)
2.4 Global Retail Drug Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Retail Drug Countries Ranking by Market Size
3 Retail Drug Competitive by Company
3.1 Global Retail Drug Revenue by Players
3.1.1 Global Retail Drug Revenue by Players (2018-2023)
3.1.2 Global Retail Drug Market Share by Players (2018-2023)
3.2 Global Retail Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Retail Drug Revenue
3.4 Global Retail Drug Market Concentration Ratio
3.4.1 Global Retail Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retail Drug Revenue in 2024
3.5 Global Key Players of Retail Drug Head office and Area Served
3.6 Global Key Players of Retail Drug, Product and Application
3.7 Global Key Players of Retail Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Retail Drug Breakdown Data by Type
4.1 Global Retail Drug Historic Revenue by Type (2018-2023)
4.2 Global Retail Drug Forecasted Revenue by Type (2024-2034)
5 Global Retail Drug Breakdown Data by Application
5.1 Global Retail Drug Historic Market Size by Application (2018-2023)
5.2 Global Retail Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Retail Drug Revenue by Company (2021-2023)
6.2 North America Retail Drug Revenue by Type (2018-2034)
6.3 North America Retail Drug Revenue by Application (2018-2034)
6.4 North America Retail Drug Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Retail Drug Revenue by Company (2021-2023)
7.2 Europe Retail Drug Revenue by Type (2018-2034)
7.3 Europe Retail Drug Revenue by Application (2018-2034)
7.4 Europe Retail Drug Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Retail Drug Revenue by Company (2021-2023)
8.2 Asia Pacific Retail Drug Revenue by Type (2018-2034)
8.3 Asia Pacific Retail Drug Revenue by Application (2018-2034)
8.4 Asia Pacific Retail Drug Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Retail Drug Revenue by Company (2021-2023)
9.2 Latin America Retail Drug Revenue by Type (2018-2034)
9.3 Latin America Retail Drug Revenue by Application (2018-2034)
9.4 Latin America Retail Drug Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Retail Drug Revenue by Company (2021-2023)
10.2 Middle East and Africa Retail Drug Revenue by Type (2018-2034)
10.3 Middle East and Africa Retail Drug Revenue by Application (2018-2034)
10.4 Middle East and Africa Retail Drug Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 CVS Caremark
11.1.1 CVS Caremark Company Details
11.1.2 CVS Caremark Business Overview
11.1.3 CVS Caremark Retail Drug Products and Services
11.1.4 CVS Caremark Retail Drug Revenue in Retail Drug Business (2018-2023)
11.1.5 CVS Caremark Retail Drug SWOT Analysis
11.1.6 CVS Caremark Recent Development
11.2 Rite Aid
11.2.1 Rite Aid Company Details
11.2.2 Rite Aid Business Overview
11.2.3 Rite Aid Retail Drug Products and Services
11.2.4 Rite Aid Retail Drug Revenue in Retail Drug Business (2018-2023)
11.2.5 Rite Aid Retail Drug SWOT Analysis
11.2.6 Rite Aid Recent Development
11.3 Target
11.3.1 Target Company Details
11.3.2 Target Business Overview
11.3.3 Target Retail Drug Products and Services
11.3.4 Target Retail Drug Revenue in Retail Drug Business (2018-2023)
11.3.5 Target Retail Drug SWOT Analysis
11.3.6 Target Recent Development
11.4 Walgreens
11.4.1 Walgreens Company Details
11.4.2 Walgreens Business Overview
11.4.3 Walgreens Retail Drug Products and Services
11.4.4 Walgreens Retail Drug Revenue in Retail Drug Business (2018-2023)
11.4.5 Walgreens Retail Drug SWOT Analysis
11.4.6 Walgreens Recent Development
11.5 Walmart
11.5.1 Walmart Company Details
11.5.2 Walmart Business Overview
11.5.3 Walmart Retail Drug Products and Services
11.5.4 Walmart Retail Drug Revenue in Retail Drug Business (2018-2023)
11.5.5 Walmart Retail Drug SWOT Analysis
11.5.6 Walmart Recent Development
12 Retail Drug Market Dynamics
12.1 Retail Drug Industry Trends
12.2 Retail Drug Market Drivers
12.3 Retail Drug Market Challenges
12.4 Retail Drug Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Retail Drug Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of Generic Drug
Table 3. Key Players of OTC Drug
Table 4. Key Players of Others
Table 5. Global Retail Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 6. Global Retail Drug Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
Table 7. Global Retail Drug Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Retail Drug Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 9. Global Retail Drug Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Table 10. Global Retail Drug Revenue by Players (2018-2023) & (US$ Million)
Table 11. Global Retail Drug Market Share by Players (2018-2023)
Table 12. Global Top Retail Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retail Drug as of 2024)
Table 13. Ranking of Global Top Retail Drug Companies by Revenue (US$ Million) in 2024
Table 14. Global 5 Largest Players Market Share by Retail Drug Revenue (CR5 and HHI) & (2018-2023)
Table 15. Global Key Players of Retail Drug, Headquarters and Area Served
Table 16. Global Key Players of Retail Drug, Product and Application
Table 17. Global Key Players of Retail Drug, Date of Enter into This Industry
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Retail Drug Market Size by Type (2018-2023) & (US$ Million)
Table 20. Global Retail Drug Revenue Market Share by Type (2018-2023)
Table 21. Global Retail Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 22. Global Retail Drug Revenue Market Share by Type (2024-2034)
Table 23. Global Retail Drug Market Size by Application (2018-2023) & (US$ Million)
Table 24. Global Retail Drug Revenue Market Share by Application (2018-2023)
Table 25. Global Retail Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 26. Global Retail Drug Revenue Market Share by Application (2024-2034)
Table 27. North America Retail Drug Revenue by Company (2021-2023) & (US$ Million)
Table 28. North America Retail Drug Revenue by Type (2018-2023) & (US$ Million)
Table 29. North America Retail Drug Revenue by Type (2024-2034) & (US$ Million)
Table 30. North America Retail Drug Revenue by Application (2018-2023) & (US$ Million)
Table 31. North America Retail Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. North America Retail Drug Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Retail Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. North America Retail Drug Revenue by Country (2024-2034) & (US$ Million)
Table 35. Europe Retail Drug Revenue by Company (2021-2023) & (US$ Million)
Table 36. Europe Retail Drug Revenue by Type (2018-2023) & (US$ Million)
Table 37. Europe Retail Drug Revenue by Type (2024-2034) & (US$ Million)
Table 38. Europe Retail Drug Revenue by Application (2018-2023) & (US$ Million)
Table 39. Europe Retail Drug Revenue by Application (2024-2034) & (US$ Million)
Table 40. Europe Retail Drug Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Europe Retail Drug Revenue by Country (2018-2023) & (US$ Million)
Table 42. Europe Retail Drug Revenue by Country (2024-2034) & (US$ Million)
Table 43. Asia Pacific Retail Drug Revenue by Company (2021-2023) & (US$ Million)
Table 44. Asia Pacific Retail Drug Revenue by Type (2018-2023) & (US$ Million)
Table 45. Asia Pacific Retail Drug Revenue by Type (2024-2034) & (US$ Million)
Table 46. Asia Pacific Retail Drug Revenue by Application (2018-2023) & (US$ Million)
Table 47. Asia Pacific Retail Drug Revenue by Application (2024-2034) & (US$ Million)
Table 48. Asia-Pacific Retail Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 49. Asia Pacific Retail Drug Revenue by Region (2018-2023) & (US$ Million)
Table 50. Asia Pacific Retail Drug Revenue by Region (2024-2034) & (US$ Million)
Table 51. Latin America Retail Drug Revenue by Company (2021-2023) & (US$ Million)
Table 52. Latin America Retail Drug Revenue by Type (2018-2023) & (US$ Million)
Table 53. Latin America Retail Drug Revenue by Type (2024-2034) & (US$ Million)
Table 54. Latin America Retail Drug Revenue by Application (2018-2023) & (US$ Million)
Table 55. Latin America Retail Drug Revenue by Application (2024-2034) & (US$ Million)
Table 56. Latin America Retail Drug Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 57. Latin America Retail Drug Revenue by Country (2018-2023) & (US$ Million)
Table 58. Latin America Retail Drug Revenue by Country (2024-2034) & (US$ Million)
Table 59. Middle East and Africa Retail Drug Revenue by Company (2021-2023) & (US$ Million)
Table 60. Middle East and Africa Retail Drug Revenue by Type (2018-2023) & (US$ Million)
Table 61. Middle East and Africa Retail Drug Revenue by Type (2024-2034) & (US$ Million)
Table 62. Middle East and Africa Retail Drug Revenue by Application (2018-2023) & (US$ Million)
Table 63. Middle East and Africa Retail Drug Revenue by Application (2024-2034) & (US$ Million)
Table 64. Middle East and Africa Retail Drug Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 65. Middle East and Africa Retail Drug Revenue by Country (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Retail Drug Revenue by Country (2024-2034) & (US$ Million)
Table 67. CVS Caremark Company Details
Table 68. CVS Caremark Business Overview
Table 69. CVS Caremark Retail Drug Product and Services
Table 70. CVS Caremark Retail Drug Revenue in Retail Drug Business (2018-2023) & (US$ Million)
Table 71. CVS Caremark Retail Drug SWOT Analysis
Table 72. CVS Caremark Recent Development
Table 73. Rite Aid Company Details
Table 74. Rite Aid Business Overview
Table 75. Rite Aid Retail Drug Product and Services
Table 76. Rite Aid Retail Drug Revenue in Retail Drug Business (2018-2023) & (US$ Million)
Table 77. Rite Aid Retail Drug SWOT Analysis
Table 78. Rite Aid Recent Development
Table 79. Target Company Details
Table 80. Target Business Overview
Table 81. Target Retail Drug Product and Services
Table 82. Target Retail Drug Revenue in Retail Drug Business (2018-2023) & (US$ Million)
Table 83. Target Retail Drug SWOT Analysis
Table 84. Target Recent Development
Table 85. Walgreens Company Details
Table 86. Walgreens Business Overview
Table 87. Walgreens Retail Drug Product and Services
Table 88. Walgreens Retail Drug Revenue in Retail Drug Business (2018-2023) & (US$ Million)
Table 89. Walgreens Retail Drug SWOT Analysis
Table 90. Walgreens Recent Development
Table 91. Walmart Company Details
Table 92. Walmart Business Overview
Table 93. Walmart Retail Drug Product and Services
Table 94. Walmart Retail Drug Revenue in Retail Drug Business (2018-2023) & (US$ Million)
Table 95. Walmart Retail Drug SWOT Analysis
Table 96. Walmart Recent Development
Table 97. Retail Drug Market Trends
Table 98. Retail Drug Market Drivers
Table 99. Retail Drug Market Challenges
Table 100. Retail Drug Market Restraints
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Retail Drug Product Picture
Figure 2. Global Retail Drug Market Size by Type (US$ Million): 2018 VS 2024 VS 2034
Figure 3. Global Retail Drug Market Share by Type: 2024 VS 2034
Figure 4. Generic Drug Features
Figure 5. OTC Drug Features
Figure 6. Others Features
Figure 7. Global Retail Drug Market Size by Application (US$ Million): 2018 VS 2024 VS 2034
Figure 8. Global Retail Drug Market Share by Application: 2024 VS 2034
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Hoem Use
Figure 12. Retail Drug Report Years Considered
Figure 13. Global Retail Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Retail Drug Market Size 2018-2034 (US$ Million)
Figure 15. Global Retail Drug Market Size Market Share by Region: 2024 VS 2034
Figure 16. Global Retail Drug Revenue Market Share by Region in 2018 VS 2024
Figure 17. Global Retail Drug Revenue Market Share Forecast by Region (2024-2034)
Figure 18. Global Top 10 Retail Drug Countries Ranking by Market Size (US$ Million) in 2024
Figure 19. Global Retail Drug Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Figure 20. Global Retail Drug Market Share by Players in 2024
Figure 21. Global Top Retail Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retail Drug as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Retail Drug Revenue in 2024
Figure 23. North America Retail Drug Revenue Market Share by Company in 2024
Figure 24. North America Retail Drug Revenue Market Share by Type (2018-2034)
Figure 25. North America Retail Drug Revenue Market Share by Application (2018-2034)
Figure 26. North America Retail Drug Revenue Share by Country (2018-2034)
Figure 27. U.S. Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 28. Canada Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 29. Europe Retail Drug Revenue Market Share by Company in 2024
Figure 30. Europe Retail Drug Revenue Market Share by Type (2018-2034)
Figure 31. Europe Retail Drug Revenue Market Share by Application (2018-2034)
Figure 32. Europe Retail Drug Revenue Share by Country (2018-2034)
Figure 33. Germany Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 34. France Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 35. U.K. Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 36. Italy Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 37. Russia Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 38. Asia Pacific Retail Drug Revenue Market Share by Company in 2024
Figure 39. Asia Pacific Retail Drug Revenue Market Share by Type (2018-2034)
Figure 40. Asia Pacific Retail Drug Revenue Market Share by Application (2018-2034)
Figure 41. Asia Pacific Retail Drug Revenue Share by Region (2018-2034)
Figure 42. China Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 43. Japan Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 44. South Korea Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 45. India Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 46. Australia Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 47. Taiwan Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 48. Indonesia Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 49. Thailand Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 50. Malaysia Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 51. Philippines Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 52. Vietnam Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 53. Latin America Retail Drug Revenue Market Share by Company in 2024
Figure 54. Latin America Retail Drug Revenue Market Share by Type (2018-2034)
Figure 55. Latin America Retail Drug Revenue Market Share by Application (2018-2034)
Figure 56. Latin America Retail Drug Revenue Share by Country (2018-2034)
Figure 57. Mexico Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 58. Brazil Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 59. Argentina Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 60. Middle East and Africa Retail Drug Revenue Market Share by Company in 2024
Figure 61. Middle East and Africa Retail Drug Revenue Market Share by Type (2018-2034)
Figure 62. Middle East and Africa Retail Drug Revenue Market Share by Application (2018-2034)
Figure 63. Middle East and Africa Retail Drug Revenue Share by Country (2018-2034)
Figure 64. Turkey Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 65. Saudi Arabia Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 66. UAE Retail Drug Revenue (2018-2034) & (US$ Million)
Figure 67. CVS Caremark Revenue Growth Rate in Retail Drug Business (2018-2023)
Figure 68. Rite Aid Revenue Growth Rate in Retail Drug Business (2018-2023)
Figure 69. Target Revenue Growth Rate in Retail Drug Business (2018-2023)
Figure 70. Walgreens Revenue Growth Rate in Retail Drug Business (2018-2023)
Figure 71. Walmart Revenue Growth Rate in Retail Drug Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed